The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
32
No.
11
November 27, 2009Nov 27, 2009
Free
DOWNLOAD THE PDF

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline

Patch-Lozenge Combination Best For Smoking Cessation

Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer

Black-White Disparity Seen In End Of Life Treatment

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

The Clinical Cancer Letter To End Print Edition In 2010

NCI Cooperative Group Clinical Trials Approved

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account